<p>The norepinephrine transporter gene (<i>SLC6A2</i>) is implicated in attention-deficit hyperactivity disorder (ADHD), but the neural mechanisms underlying this association remain poorly understood. This study explored whether a <i>SLC6A2</i> haplotype affected functional brain activations in children with ADHD. We evaluated 109 drug-naïve children with ADHD, including 48 carriers of the <i>SLC6A2</i> rs36011 (T)/rs1566652 (G) haplotype and 61 non-carriers, and 121 typically developing children (TDC), comprising 64 with and 57 without the TG haplotype. Functional brain activations were measured using the counting Stroop task during functional magnetic resonance imaging. Compared to TDC, children with ADHD exhibited reduced brain activations in the bilateral middle temporal gyri (MTG) and the right postcentral gyrus. Furthermore, the TG haplotype carriers exhibited reduced brain activations in the left anterior cingulate cortex (ACC), inferior frontal gyrus (IFG), and left MTG compared to non-carriers. Significant interactions between the presence of ADHD and the TG haplotype were found in the left ACC, left MTG, and left precuneus, underscoring the synergistic effects of ADHD and genetic factors on brain function. The present study identified significant alterations in brain activations linked to the <i>SLC6A2</i> genotype in specific brain areas, such as the ACC, IFG, and MTG. The findings enhanced our understanding of the unique impact of the <i>SLC6A2</i> rs36011 (T)/rs1566652 (G) haplotype on the neurophysiology of individuals with ADHD. Our results highlighted the <i>SLC6A2</i> genotype’s functional consequences and further elucidated its role in the neurobiological mechanisms of ADHD.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

The norepinephrine transporter gene modulates functional brain activations in drug-naïve children with attention-deficit/hyperactivity disorder

  • Chi-Yung Shang,
  • Li-Ying Fan,
  • Tai-Li Chou,
  • Susan Shur-Fen Gau

摘要

The norepinephrine transporter gene (SLC6A2) is implicated in attention-deficit hyperactivity disorder (ADHD), but the neural mechanisms underlying this association remain poorly understood. This study explored whether a SLC6A2 haplotype affected functional brain activations in children with ADHD. We evaluated 109 drug-naïve children with ADHD, including 48 carriers of the SLC6A2 rs36011 (T)/rs1566652 (G) haplotype and 61 non-carriers, and 121 typically developing children (TDC), comprising 64 with and 57 without the TG haplotype. Functional brain activations were measured using the counting Stroop task during functional magnetic resonance imaging. Compared to TDC, children with ADHD exhibited reduced brain activations in the bilateral middle temporal gyri (MTG) and the right postcentral gyrus. Furthermore, the TG haplotype carriers exhibited reduced brain activations in the left anterior cingulate cortex (ACC), inferior frontal gyrus (IFG), and left MTG compared to non-carriers. Significant interactions between the presence of ADHD and the TG haplotype were found in the left ACC, left MTG, and left precuneus, underscoring the synergistic effects of ADHD and genetic factors on brain function. The present study identified significant alterations in brain activations linked to the SLC6A2 genotype in specific brain areas, such as the ACC, IFG, and MTG. The findings enhanced our understanding of the unique impact of the SLC6A2 rs36011 (T)/rs1566652 (G) haplotype on the neurophysiology of individuals with ADHD. Our results highlighted the SLC6A2 genotype’s functional consequences and further elucidated its role in the neurobiological mechanisms of ADHD.